Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 26 of 39

  1. datopotamab deruxtecan

    DATOPOTAMAB DERUXTECAN DAIICHI SANKYO

    EMA: approved Β· PMDA: approved

    L01FX35
  2. defatted powder of arachis hypogaea l., semen (peanuts)

    PALFORZIA

    EMA: approved

    V01
  3. defibrotide

    DEFITELIO

    EMA: approved

    B01AX01
  4. degarelix

    FIRMAGON 120MG Ferring Pharmaceuticals

    EMA: approved Β· TGA: approved

    L02BX02
  5. delafloxacin

    QUOFENIX

    EMA: approved

    J01MA23
  6. delamanid

    DELTYBA

    EMA: approved Β· PMDA: approved

    J04AK06
  7. depemokimab

    EXDENSUR

    EMA: approved

    R03DX12
  8. dexmedetomidine

    DEXDOR

    EMA: approved Β· NMPA: clinical trials

    N05CM18
  9. dexrazoxane

    SAVENE

    EMA: approved

    V03AF02
  10. dibotermin alfa

    INDUCTOS

    EMA: approved

    M05BC01
  11. difelikefalin

    KORSUVA Seqirus (Australia) Pty Ltd

    EMA: approved Β· TGA: approved

    V03AX
  12. dinutuximab beta

    QARZIBA (PREVIOUSLY DINUTUXIMAB BETA EUSA AND DINUTUXIMAB BETA APEIRON)

    EMA: approved

    L01FX06
  13. diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed)

    INFANRIX HEXA

    EMA: approved

    J07CA09
  14. diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed)

    HEXYON

    EMA: approved

    J07CA09
  15. diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)

    VAXELIS

    EMA: approved

    J07CA09
  16. donanemab

    KISUNLA

    EMA: approved Β· PMDA: approved

    N06DX05
  17. donidalorsen

    DAWNZERA

    EMA: approved

    B06AC
  18. dostarlimab

    JEMPERLI GlaxoSmithKline

    EMA: approved Β· TGA: approved

    L01FF07
  19. doxorubicin

    ADRIAMYCIN Pfizer Australia Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01DB
  20. ebola zaire vaccine (rvsvβˆ†g-zebov-gp, live)

    ERVEBO

    EMA: approved

  21. edotreotide

    SOMAKIT TOC

    EMA: approved

    V09IX
  22. efanesoctocog alfa

    ALTUVOCT

    EMA: approved

    B02BD02
  23. efbemalenograstim alfa

    RYZNEUTA

    EMA: approved

    L03AA18
  24. efmoroctocog alfa

    ELOCTA

    EMA: approved

    B02BD02

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.